- ROUNDTABLE: Pharmacy’s future in sync with technology
- Coalition of healthcare industry stakeholders address best practices regarding controlled substances
- NACDS RxImpact shines spotlight on pharmacists' increasing role in delivery of healthcare services
- Study from NCPA sheds new light on med synchronization programs
- Senate passes Drug Quality and Security Act
COVINGTON, Ky. — Pharmaceutical services provider Omnicare celebrated its 30th anniversary as a public company by ringing the closing bell at the New York Stock Exchange at 4 p.m. on Thursday, the company said.
CEO John Figueroa presided over the ringing of the bell to mark the occasion, the company said, as did other members of the company's senior leadership team and 30-year employee Tom Marsh.
"It is an honor to ring The Closing Bell to celebrate this important milestone in our company's history," Figueroa said. "Over the last 30 years, Omnicare has grown from a small service provider to hospitals into a true leader in professional pharmacy, related consoling and data management services for skilled nursing, assisted living and other chronic care institutions. Additionally, we have built a comprehensive specialty care business, which serves the rapidly growing specialty pharmaceuticals market. We have a proud and rich history, and today we salute three decades of Omnicare's dedicated service to our nation's elderly and noters with specialized pharmaceutical needs."
The company was incorporated on May 19, 1981 and listed on the NYSE on Dec. 29 of that year. The company will also mark its 30th anniversary with a "30 Days of Giving" campaign, spending the month of October offering opportunities for employees to get involved in charitable works and conducting a companywide United Way campaign.